19 June 2013
Keywords: fda, awards, priority, review, prasugrel, drug, major
Article | 03 March 2008
US drug major Eli Lilly and Japan's Daiichi Sankyo say that the filing
for their co-devloped anti-coagulant prasugrel has been ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 March 2008
18 June 2013
© 2013 thepharmaletter.com